In a side-by-side clinical comparison, a more significant decrease in wound size was achieved in wounds treated with Multidex® wound dressings versus using wet-to-dry dressings.

In a side-by-side clinical comparison, a more significant decrease in wound size was achieved in wounds treated with Multidex® wound dressings versus using wet-to-dry dressings.

Chronic or non-healing wounds are some of the most difficult and expensive to treat, and may never heal. However, Multidex® dressing has been successfully treating hard-to-heal wounds for over 25 years. Beginning with Dr. Silvetti’s ground breaking research in the early 1980s, a more significant decrease in wound size was achieved in wounds treated with

Multidex® wound dressings versus using wet-to-dry dressings.** – Multidex® dressing time and time again has worked when other products and techniques have failed or stalled.

This study describes a cost effective limb preservation protocol for diabetic foot patients indicated for limb amputation in a low income developing country. The protocol uses Multidex® maltodextrin/ascorbic acid dressing (DeRoyal®, Tennessee, USA) as a primary dressing and gauze as a secondary dressing following  transmetatarsal amputation.